The initial deductible on prescription drug reimbursements will change, affecting medication costs for many
5.12.2024 10:15:45 EET | Kela/FPA | Press release
Parliament has approved changes to the initial deductible on reimbursements of medicine costs. The initial deductible will go up from 50 euros to 70 euros in January 2025. In addition, the initial deductible will be tied to the National Pensions Index and will be reviewed annually.
Parliament has approved the changes the Government proposed to the initial deductible on reimbursements of prescription medicine costs. The Government seeks to lower reimbursement spending by 90 million euros.
On 1 January 2025, the initial deductible on reimbursements of medicine costs will go up from 50 euros to 70 euros. In addition, the initial deductible will be tied to the National Pensions Index, so that it will be index adjusted every year.
"The National Pensions Index reflects changes in the general cost of living”, says Vilja Juvonen, a legal counsel at Kela. “If the cost of living rises, so does the National Pensions Index, in turn increasing the initial deductible.”
Kela provides reimbursements for the costs of medicinal products, clinical nutritional products and emollient creams that have been prescribed for the treatment of an illness. Costs exceeding an annual initial deductible can be reimbursed. The initial deductible is applied from the beginning of the year in which a person turns 19.
The amount reimbursed depends on the specific medicine and the reimbursement entitlements granted. There are three categories of reimbursement: basic, lower special and higher special.
Fewer people will receive reimbursements as a result of the higher initial deductible
In 2023, about 55% of Finns, a little over 3 million persons, qualified for reimbursement of prescription medicine costs. Total expenditure on the reimbursements amounted to 1,779 million euros, most of which was accounted for by the reimbursements in the higher special category. Over-65s were the single largest group of reimbursement recipients.
“The higher initial deductible will have the greatest impact on those who need medicines in the higher special reimbursement category. The people who need such medicines often have multiple illnesses, little income and are on average older than others who purchase medicines”, Juvonen says.
The number of reimbursement recipients has increased over the past few years. In 2023, the number of recipients was up by 1.7% (a little over 51,000) year-on-year. In 2022, the number of reimbursement recipients grew by 84,000.
“We estimate that the higher initial deductible will reduce the number of reimbursement recipients by about 226,000. The under-45 age groups will have the largest number of people who do not clear the initial deductible threshold”, Juvonen says.
The changes in the initial deductible will go into effect automatically. The process of claiming reimbursement for medicine costs will remain unchanged.
Typically, the reimbursement is calculated off the price of the medicine at the pharmacy. If this is not the case or if a customer had to buy medicine before Kela had granted them a right to reimbursement, the reimbursement must be claimed afterwards from Kela.
Customers do not have to do anything in response to the change and do not need to contact Kela.
Learn more
Contacts
Vilja JuvonenLegal CounselKela
Tel:050 476 4144firstname.lastname@kela.fiKela's Communications UnitFor media enquiries, please contact us between 9:00 and 16:00, Monday to Friday. This number can be used for interview requests, which we will be happy to forward to an appropriate source at Kela. You can also submit interview requests by email.
Tel:+358 20 634 7745viestinta@kela.fiAlternative languages
Subscribe to releases from Kela/FPA
Subscribe to all the latest releases from Kela/FPA by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Kela/FPA
Ansök om FPA:s gradupris för en 2025 godkänd avhandling som behandlar sociala tryggheten4.2.2026 06:00:00 EET | Pressmeddelande
FPA beviljar ett pris för en förtjänstfull pro gradu-avhandling som godkänts förra året. Prissumman är 2 000 euro. Ansök om priset senast 31.3.2026.
Kelan gradupalkintoa voi hakea vuonna 2025 hyväksytylle sosiaaliturvaa käsittelevälle gradulle4.2.2026 06:00:00 EET | Tiedote
Kela myöntää palkinnon viime vuonna hyväksytylle ansiokkaalle pro gradu -työlle. Palkinnon arvo on 2 000 euroa. Palkintoa tulee hakea viimeistään 31.3.2026.
Kutsu mediatilaisuuteen 10.2.2026: Mitä toimeentulotukilain muutokset tarkoittavat ja keihin ne kohdistuvat?3.2.2026 10:14:34 EET | Tiedote
Toimeentulotukilakiin tehdyt muutokset tiukensivat tuen saamisen ehtoja 1.2.2026 alkaen. Perustoimeentulotuki säilyy viimesijaisena tukena ja toimeentulotuen turvana, mutta uudistuksen tarkoituksena on vahvistaa sen roolia tilapäisenä apuna.
FPA:s utlåtande: Ett smidigare informationsutbyte främjar verkställigheten av förmåner och en jämlik behandling av kunderna3.2.2026 09:13:33 EET | Pressmeddelande
FPA understöder utkastet till regeringens proposition med förslag till ändring av lagstiftningen om Folkpensionsanstaltens informationsutbyte. I sitt utlåtande lyfter FPA fram att den föreslagna lagändringen möjliggör en smidigare handläggning av förmåner, mindre administrativ belastning på kunderna och en jämlikare behandling av kunderna samt leder till att eventuellt missbruk av förmåner minskar.
Kelan lausunto: sujuvampi tiedonvaihto vahvistaisi etuuksien toimeenpanoa ja asiakkaiden yhdenvertaisuutta3.2.2026 09:13:33 EET | Tiedote
Läs meddelandet på svenska (fpa.fi). Kela kannattaa hallituksen esitysluonnosta Kansaneläkelaitoksen tietojenvaihtoa koskevan lainsäädännön muuttamiseksi. Lausunnossaan Kela korostaa, että lakimuutos sujuvoittaisi etuuksien käsittelyä, vähentäisi asiakkaiden asiointiin liittyvää hallinnollista kuormitusta, edistäisi asiakkaiden yhdenvertaisuutta sekä vähentäisi mahdollisia etuuksien väärinkäyttötapauksia.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom